Cartesian Therapeutics, Inc. (RNAC) Capital expenditures 2016–2025
Cartesian Therapeutics, Inc. (RNAC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5.5MFY2025 · since FY2016: $586,000 → $5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.5M | -40.0% |
| FY2024 | $9.1M | +4314.1% |
| FY2023 | $206,000 | -82.8% |
| FY2022 | $1.2M | +10.7% |
| FY2021 | $1.1M | +33.1% |
| FY2020 | $815,000 | +1634.0% |
| FY2019 | $47,000 | -94.7% |
| FY2018 | $884,000 | +20.6% |
| FY2017 | $733,000 | +25.1% |
| FY2016 | $586,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice